Trajectories of Host-Response Subphenotypes in Patients With COVID-19 Across the Spectrum of Respiratory Support.

COVID-19 acute lung injury acute respiratory failure biomarkers host response longitudinal subphenotypes

Journal

CHEST critical care
ISSN: 2949-7884
Titre abrégé: CHEST Crit Care
Pays: United States
ID NLM: 9918681585806676

Informations de publication

Date de publication:
Dec 2023
Historique:
medline: 22 1 2024
pubmed: 22 1 2024
entrez: 22 1 2024
Statut: ppublish

Résumé

Hospitalized patients with severe COVID-19 follow heterogeneous clinical trajectories, requiring different levels of respiratory support and experiencing diverse clinical outcomes. Differences in host immune responses to SARS-CoV-2 infection may account for the heterogeneous clinical course, but we have limited data on the dynamic evolution of systemic biomarkers and related subphenotypes. Improved understanding of the dynamic transitions of host subphenotypes in COVID-19 may allow for improved patient selection for targeted therapies. We examined the trajectories of host-response profiles in severe COVID-19 and evaluated their prognostic impact on clinical outcomes. In this prospective observational study, we enrolled 323 inpatients with COVID-19 receiving different levels of baseline respiratory support: (1) low-flow oxygen (37%), (2) noninvasive ventilation (NIV) or high-flow oxygen (HFO; 29%), (3) invasive mechanical ventilation (27%), and (4) extracorporeal membrane oxygenation (7%). We collected plasma samples on enrollment and at days 5 and 10 to measure host-response biomarkers. We classified patients by inflammatory subphenotypes using two validated predictive models. We examined clinical, biomarker, and subphenotype trajectories and outcomes during hospitalization. IL-6, procalcitonin, and angiopoietin 2 persistently were elevated in patients receiving higher levels of respiratory support, whereas soluble receptor of advanced glycation end products (sRAGE) levels displayed the inverse pattern. Patients receiving NIV or HFO at baseline showed the most dynamic clinical trajectory, with 24% eventually requiring intubation and exhibiting worse 60-day mortality than patients receiving invasive mechanical ventilation at baseline (67% vs 35%; Longitudinal study of the systemic host response in COVID-19 revealed substantial and predictive interindividual variability influenced by baseline levels of respiratory support.

Sections du résumé

BACKGROUND BACKGROUND
Hospitalized patients with severe COVID-19 follow heterogeneous clinical trajectories, requiring different levels of respiratory support and experiencing diverse clinical outcomes. Differences in host immune responses to SARS-CoV-2 infection may account for the heterogeneous clinical course, but we have limited data on the dynamic evolution of systemic biomarkers and related subphenotypes. Improved understanding of the dynamic transitions of host subphenotypes in COVID-19 may allow for improved patient selection for targeted therapies.
RESEARCH QUESTION OBJECTIVE
We examined the trajectories of host-response profiles in severe COVID-19 and evaluated their prognostic impact on clinical outcomes.
STUDY DESIGN AND METHODS METHODS
In this prospective observational study, we enrolled 323 inpatients with COVID-19 receiving different levels of baseline respiratory support: (1) low-flow oxygen (37%), (2) noninvasive ventilation (NIV) or high-flow oxygen (HFO; 29%), (3) invasive mechanical ventilation (27%), and (4) extracorporeal membrane oxygenation (7%). We collected plasma samples on enrollment and at days 5 and 10 to measure host-response biomarkers. We classified patients by inflammatory subphenotypes using two validated predictive models. We examined clinical, biomarker, and subphenotype trajectories and outcomes during hospitalization.
RESULTS RESULTS
IL-6, procalcitonin, and angiopoietin 2 persistently were elevated in patients receiving higher levels of respiratory support, whereas soluble receptor of advanced glycation end products (sRAGE) levels displayed the inverse pattern. Patients receiving NIV or HFO at baseline showed the most dynamic clinical trajectory, with 24% eventually requiring intubation and exhibiting worse 60-day mortality than patients receiving invasive mechanical ventilation at baseline (67% vs 35%;
INTERPRETATION CONCLUSIONS
Longitudinal study of the systemic host response in COVID-19 revealed substantial and predictive interindividual variability influenced by baseline levels of respiratory support.

Identifiants

pubmed: 38250011
doi: 10.1016/j.chstcc.2023.100018
pmc: PMC10798236
pii:
doi:

Types de publication

Journal Article

Langues

eng

Auteurs

Michael Lu (M)

Internal Medicine Residency Program, University of Pittsburgh, Pittsburgh, PA.

Callie Drohan (C)

Internal Medicine Residency Program, University of Pittsburgh, Pittsburgh, PA.

William Bain (W)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Faraaz A Shah (FA)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Matthew Bittner (M)

Internal Medicine Residency Program, University of Pittsburgh, Pittsburgh, PA.

John Evankovich (J)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Niall T Prendergast (NT)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.

Matthew Hensley (M)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.

Tomeka L Suber (TL)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Meghan Fitzpatrick (M)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Raj Ramanan (R)

Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.

Holt Murray (H)

Department of Critical Care Medicine, University of Pittsburgh, Pittsburgh, PA.

Caitlin Schaefer (C)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Shulin Qin (S)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA.

Xiaohong Wang (X)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA.

Yingze Zhang (Y)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Seyed M Nouraie (SM)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Heather Gentry (H)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.

Cathy Murray (C)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.

Asha Patel (A)

Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA.

Bernard J Macatangay (BJ)

Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA.

Jana Jacobs (J)

Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA.

John W Mellors (JW)

Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA.

Janet S Lee (JS)

Division of Pulmonary and Critical Care, Washington University School of Medicine, Saint Louis, MO.

Prabir Ray (P)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Anuradha Ray (A)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.

Barbara Methé (B)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA.

Alison Morris (A)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA.

Bryan J McVerry (BJ)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.
Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA.
Division of Infectious Diseases, University of Pittsburgh, Pittsburgh, PA.

Georgios D Kitsios (GD)

Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, University of Pittsburgh, Pittsburgh, PA.
Acute Lung Injury Center of Excellence, University of Pittsburgh, Pittsburgh, PA.
Center for Medicine and the Microbiome, University of Pittsburgh, Pittsburgh, PA.

Classifications MeSH